ABMC Cleared on Drug Abuse Screening Test
Posted on: Wednesday, 31 May 2006, 12:00 CDT
American Bio Medica Corp. said Wednesday it is cleared to market its Rapid TOX test that screens urine for a variety of abused drugs.
The company said the Food and Drug Administration has approved the new rapid test, which uses a horizontal cassette platform to simultaneously detect two to 10 commonly abused drugs in a urine specimen.
Rapid TOX has opened up a lot of doors for us in the workplace and occupational health markets and has helped us to provide another cost effective drug test to the criminal justice market, ABMC Chief Executive Officer Stan Cipkowski said in a statement.
This FDA clearance will now allow us to complete a relationship with a global partner and offer hospitals and physicians an alternative product for use in emergency rooms and patient drug testing programs, he said.
ABMC said the newly approved test can be used with its previously approved Rapid Reader drug screen result interpretation and data management system.
Source: United Press International
Related Articles
- New Florida Law Allows Use of Instant Drug Tests On the Job Site
- New Genetic Breast Cancer Test is Approved
- CLSI Publishes Guideline for Toxicology and Drug Testing in the Clinical Laboratory
- FDA Eyes Drug Tests Done by Canadian Lab
- Drug Testing at Muhlenberg?
- Forget Drug Tests; Show Jail Inmates Videos
- Dalhart ISD Approves Drug Testing
- Problems With Urine Drug Testing Surface Nationwide
- Camden School Board Tables Decision on Drug Testing Debate Will Continue on July 12, Pending a Look at Other Options Affecting Students in Interscholastic Activities.
- U.S. Food and Drug Administration (FDA) Approves BARACLUDE(TM) (Entecavir) for Treatment of Chronic Hepatitis B
 |
 |
User Comments (0)
RSS Feeds